Core Laboratories (CLB) Misses Q3 EPS by 4c, Guidance Comes in Light
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks rally, crude prices fall
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
Core Lab Reports Q3 2016 Results:
October 19, 2016 4:12 PM EDTAMSTERDAM, Oct. 19, 2016 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported third quarter 2016 revenue of $143,500,000, down 3% sequentially from the second quarter 2016, with earnings per diluted share ("EPS") of $0.38, in accordance with U.S. generally accepted accounting principles ("GAAP"), flat from the second quarter 2016. Third quarter 2016 net income ("NI") was $16,700,000; operating income was $21,500,000; and operating margins were 15%, all of which were up from the second quarter of 2016 as Core's cost reduction, multi-skilling, and lab automation programs continue to produce positive financial results for the... More
